SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy
1 references·0 citing·4 second hop
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy (2022)Chiral Switch: Between Therapeutical Bene…The strategy of enantiomer patents of drugs (2010)The strategy of enantiomer pa…Intellectual property and chirality of drugs (1999)Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades (2012)The predicated demise of racemic new molecular entities is an exaggeration (2012)“New Drug” Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity (2014)
this work references cited by second hop

References

  • 2010The strategy of enantiomer patents of drugs61 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work